Clinical Trial Update: Icodextrin Effects on Glucose Transporter Activation and Mediators of Fibrosis

View source ↗

Summary

A completed clinical trial evaluating icodextrin's effect on glucose transporter activation and mediators of fibrosis in end-stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Extraneal (icodextrin)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: End Stage Renal Disease | Status: COMPLETED